{
 "edition": "20260921-21",
 "language": "en",
 "period_start": "2026-09-21T21:00:00+09:00",
 "period_end": "2026-09-22T00:00:00+09:00",
 "page": 2,
 "pages": 2,
 "received_in_period": 104,
 "listed_in_period": 104,
 "description": "One place for news and notices from 1 countries/regions: Taiwan, 104 items from 4 sources.One edition every 180 minutes: every item from every source received in the period, with the original link.",
 "countries": [
  {
   "code": "TW",
   "name": "Taiwan",
   "items": 104,
   "sources": 4
  }
 ],
 "number_of_items": 4,
 "items": [
  {
   "id": 2902887,
   "anchor": "n2902887",
   "permalink": "https://ainews.idaeo.ai/180m/20260921-21/index-en-p2.html#n2902887",
   "title": "09/21 Biotech Stock Update - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "Second cash capital increase in 115: 10 million shares",
     "state": "translated",
     "quote": "115年第二次現增1000萬股"
    },
    {
     "text": "5 yuan per share",
     "state": "translated",
     "quote": "每股5元"
    }
   ],
   "companies": [
    "育世博-KY",
    "ADC",
    "全福生技",
    "康霈",
    "安盛生"
   ],
   "published_at": "2026-09-21T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90279&range=news",
   "link_level": "source",
   "link_label": "Original",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2902886,
   "anchor": "n2902886",
   "permalink": "https://ainews.idaeo.ai/180m/20260921-21/index-en-p2.html#n2902886",
   "title": "訊聯細胞智藥 expands into Japan; 2 new products receive approval as quasi-drugs - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "2 new products",
     "state": "translated",
     "quote": "2項新品"
    },
    {
     "text": "Growth of more than 2 times",
     "state": "translated",
     "quote": "成長逾2倍"
    },
    {
     "text": "Compound annual growth rate exceeds 7成",
     "state": "translated",
     "quote": "複合成長率則突破7成"
    }
   ],
   "companies": [
    "訊聯細胞智藥",
    "日本厚生勞動省"
   ],
   "published_at": "2026-09-21T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90267",
   "link_level": "source",
   "link_label": "Original",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2902885,
   "anchor": "n2902885",
   "permalink": "https://ainews.idaeo.ai/180m/20260921-21/index-en-p2.html#n2902885",
   "title": "聯生藥 UB-221 scores success in Phase 2 Chinese urticaria trial; plans to launch Phase 3 and overseas Phase 2 food allergy trials - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "Phase 2 clinical trial for chronic spontaneous urticaria",
     "state": "translated",
     "quote": "慢性自發性蕁麻疹臨床二期試驗"
    },
    {
     "text": "Phase 3 clinical trial planning",
     "state": "translated",
     "quote": "臨床三期試驗規劃"
    }
   ],
   "companies": [
    "聯生藥",
    "AscendantHealth",
    "正啟生物",
    "揚州世之源生物科技",
    "GenesisLifeSciences",
    "聯生藥揚州科技"
   ],
   "published_at": "2026-09-21T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90265",
   "link_level": "source",
   "link_label": "Original",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2902884,
   "anchor": "n2902884",
   "permalink": "https://ainews.idaeo.ai/180m/20260921-21/index-en-p2.html#n2902884",
   "title": "中山醫大 launches Taiwan-Japan care technology innovation hub, linking industry, academia and medicine to bring technology into practice - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [],
   "companies": [
    "中山醫學大學",
    "台灣高齡產業創新發展協會",
    "嗶嗶嗶樂遊學股份有限公司"
   ],
   "published_at": "2026-09-21T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90266",
   "link_level": "source",
   "link_label": "Original",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  }
 ]
}